Possible causes of Alzheimer's disease: Amyloid fragments, free radicals, and calcium homeostasis

Neurobiology of Disease

Volumn 5, Issue 3, 1998, Pages 129-141

  Hölscher, Christian ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Calcium channels; Free radicals; Growth factors; Nitric oxide; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; CALCIUM; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; FREE RADICAL; GLUTAMATE RECEPTOR; GROWTH FACTOR; NITRIC OXIDE SYNTHASE;

AGED; AGING; ALZHEIMER DISEASE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; COGNITION; DEMENTIA; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; PERIKARYON; PRIORITY JOURNAL; REVIEW;

EID: 0344936729     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1998.0193     Document Type: Review

References (140)

1. 2+-dependent late phase. J. Neurochem. 67, 2074-2078.
2. Akama, K. T., Albanese, C., Pestell, R. G., & Van, E. L. (1998) Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism. Proc. Natl. Acad. Sci. USA 95, 5795-5800.
3. Arendt, T., Bruckner, M., Gertz, H., & Marcova, L. (1998) Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain. Neuroscience 83, 991-1002.
4. 2+ channels provides a mechanism for neuronal death in Alzheimer's disease. Ann. N.Y Acad. Sci. 747, 256-266.
5. Barger, S. W., Fiscus, R. R., Ruth, P., Hofmann, F., & Mattson, M. P. (1995) Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor. J. Neurochem. 64, 2087-2096.
6. Blacker, D., Haines, J. L., Rodes, L., Terwedow, H., Go, R., Harrell, L. E., Perry, R. T., Bassett, S. S., Chase, G., Meyers, D., Albert, M. S., & Tanzi, R. (1997) ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative. Neurology 48, 139-147.
7. Bliss, T. V. P., & Collingridge, G. L. (1993) A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361, 31-39.
8. Braak, E., & Braak, H. (1997) Alzheimer's disease: Transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon's horn. Acta Neuropathol. (Berlin) 93, 323-325.
9. Braak, H., & Braak, E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259.
10. Brinning, S., Chen, X., & Yergey, A. (1997) The roles of conformation and aggregation in toxicity of beta-amyloid peptide (1-40) characterized with congo red. Soc. Neurosci. Meeting New Orleans 23, 634.10.
11. Busciglio, J., Lorenzo, A., & Yankner, B. A. (1992) Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging 13, 609-612.
12. Buxbaum, J. D., Oishi, M., and Chen, H. (1992) Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer β/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA 89, 10075-10078.
13. Cai, X. D., Golde, T. E., & Younkin, S. G. (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514-516.
14. Cheng, B., & Mattson, M. P. (1994) NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res. 640, 56-67.
15. Clarris, H. J., Nurcombe, V., Small, D. H., Beyreuther, K., & Masters, C. L. (1994) Secretion of nerve growth factor from septum stimulates neurite outgrowth and release of the amyloid protein precursor of Alzheimer's disease from hippocampal explants. J. Neurosci. Res. 38, 248-258.
16. Connop, B. P., Boegman, R. J., Jhamandas, K., & Beninger, R. J. (1995) Excitotoxic action of NMDA agonists on nigrostriatal dopaminergic neurons: Modulation by inhibition of nitric oxide synthesis. Brain Res. 676, 124-132.
17. Copani, A., Bruno, V., Battaglia, G., Leanza, G., Pelliteri, R., Russo, A., Stanzani, S., & Nicoletti, F. (1995) Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by β-amyloid peptide. Mol. Pharmacol. 47, 890-897.
18. Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet. 7, 180-184.
19. Cowburn, R. F., Wiehager, B., & Sundström, E. (1995) β-Amyloid peptides enhance binding of the calcium mobilising second messengers inositol (1,4,5)trisphosphate and inositol(1,3,4,5)-tetrakisphosphate to their receptor sites in rat cortical membranes. Neurosci. Lett. 191, 31-34.
20. Cullen, W. K., Wu, J. Q., Anwyl, R., & Rowan, M. J. (1996) Beta-amyloid produces a delayed NMDA receptor-dependent reduction in synaptic transmission in rat hippocampus. Neuroreport 8, 87-92.
21. Delobette, S., Privat, A., & Maurice, T. (1997) In vitro aggregation facilitates beta-amyloid peptide-(25-35)-induced amnesia in the rat. Eur. J. Pharmacol. 319, 1-4.
22. Disterhoft, J. F., Moyer, J. R., & Thompson, L. T. (1994) The calcium rationale in aging and Alzheimer's disease. In: Calcium Hypothesis of Aging and Dementia, pp. 382-405. Ann. Acad. Sci. N.Y., New York.
23. Doré, S., Kar, S., & Quirion, R. (1997) Rediscovering an old friend, IGF-I: Potential use in the treatment of neurodegenerative diseases. Trends Neurosci. 20, 326-331.
24. Doyle, E., Bruce, M. T., Breen, K. C., Smith, D. C., Anderton, B. A., & Regan, C. M. (1990) Intraventricular infusion of antibodies to amyloid-β-protein precursor impairs the acquisition of a passive avoidance response in the rat. Neurosci. Lett. 115, 97-102.
25. Edelberg, H. K., & Wei, J. Y. (1996) The biology of Alzheimer's disease. Mech. Ageing Dev. 91, 95-114.
26. Eikelenboom, P., Zhan, S. S., van Gool, W. A., & Allsop, D. (1994) Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol. Sci. 15, 447-450.
27. Engström, I., Ronquist, G., Pettersson, L., & Waldenström, A. (1995) Alzheimer amyloid β-peptides exhibit ionophore like properties in human erythrocytes. Eur. J. Clin. Invest. 25, 471-476.
28. Evans, D. A., Funkenstein, H. H., Altert, M. S., Scherr, P. A., Cook, N. R., Chown, M. J., Herbert, L. E., Hennekens, C. H., & Taylor, J. O. (1989) Prevalence of Alzheimer's disease in a community population of older persons. JAMA 262, 2551-2556.
29. Farooqui, A. A., & Horrocks, L. A. (1994) Involvement of glutamate receptors, lipases, and phospholipases in long-term potentiation and neurodegeneration. J. Neurosci. Res. 38, 6-11.
30. Frautschy, S. A., Baird, A., & Cole, G. M. (1991) Effects of injected Alzheimer β-amyloid cores in rat brain. Proc. Natl. Acad. Sci. USA 88, 8362-8366.
31. + channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature 379, 74-78.
32. Games, D., Adams, D., Alessandrini, R. R. B. P. B., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., Guido, T., Hagopian, S., Johnson-Wood, K., Khan, K., Lee, M., Leibowitz, P., Lieberburg, I., Little, S., Masliah, E., McConlogue, L., Montoya-Zavala, M., Mucke, L., Paganini, L., Penniman, E., Power, M., Schenk, D., Seubert, P., Snyder, B., Soriano, F., Tan, H., Vitale, J., Wadsworth, S., Wolozin, B., & Zhao, J. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523-527.
33. Games, D., Khan, K. M., Soriano, F. G., Keim, P. S., Davis, D. L., Bryant, K., & Lieberburg, I. (1992) Lack of Alzheimer pathology after β-amyloid protein injections in rat brain. Neurobiol. Aging 13, 569-576.
34. Gillian, A. M., McFarlane, I., Lucy, F. M., Overly, C., McConlogue, L., & Breen, K. C. (1997) Individual isoforms of the amyloid beta precursor protein demonstrate differential adhesive potentials to constituents of the extracellular matrix. J. Neurosci. Res. 49, 154-160.
35. Giovanelli, L., Casamenti, F., Scali, C., Bartolini, L., & Pepeu, G. (1995) Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience 66, 781-792.
36. Gooch, M. D., & Stennett, D. J. (1996) Molecular basis of Alzheimer's disease. Am. J. Health Syst. Pharm. 53, 1545-1557.
37. Good, P. F., Werner, P., Hsu, A., Olanow, C. W., & Perl, D. P. (1996) Evidence for neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol 149, 21-28.
38. 2+ and excitability in a modeled neuron. Proc. Natl Acad. Sci. USA 93, 15130-15135.
39. Goodman, Y., & Mattson, M. P. (1996) Ceramide protects hippocampal neurons against excitotoxic and oxidative insults and amyloid β-peptide toxicity. J. Neurochem. 66, 869-872.
40. Gray, C. W., & Patel, A. J. (1995) Neurodegeneration mediated by glutamate and β-amyloid peptide: A comparison and possible interaction. Brain Res. 691, 169-179.
41. Greenberg, B. D., Savage, M. J., Howland, D. S., Ali, S. M., Siedlak, S. L. G. P., Siman, R., & Scott, R. W. (1996) APP transgenesis: Approaches toward the development of animal models for Alzheimer disease neuropathology. Neurobiol. Aging 17, 153-171.
42. Guo, Q., Furukawa, K., Sopher, B. L., Pham, D. G., Xie, J., Robinson, N., Martin, G. M., & Mattson, M. P. (1996) Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid beta-peptide. Neuroreport 8, 379-383.
43. Handy, R. L. C., Harb, H. L., Wallace, P., Gaffen, Z., Whitehead, K. J., & Moore, P. K. (1996) Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: Antinociceptive and cardiovascular effects. Br. J. Pharmacol. 119, 423-431.
44. Harrigan, M. R., Kunkel, D. D., Nguyen, L. B., & Malouf, A. T. (1995) Beta amyloid is neurotoxic in hippocampal slice cultures. Neurobiol. Aging 16, 779-789.
45. Hölscher, C. (1995) Release of prostaglandins during memory consolidation in the chick. Eur. J. Pharmacol. 294, 253-259.
46. Hölscher, C., McGlinchey, L., Anwyl, R., & Rowan, M. (1996) 7-Nitro indazole, a selective neuronal nitric oxide synthase inhibitor, impairs spatial learning in the rat. Learning Memory 2, 267-278.
47. Hölscher, C., McGlinchey, L., & Rowan, M. J. (1996) L-AP4 (L-(+)-2-amino-4-phosphonobutyric acid) induced impairment of spatial learning in the rat is antagonized by MAP4 ((S)-2-amino-2-methyl 1-4-phosphonobutanoic acid). Behav. Brain Res. 81, 69-79.
48. Hölscher, C. (1997) Nitric oxide, the enigmatic neuronal messenger: Its role in synaptic plasticity. Trends Neurosci. 20, 298-303.
49. Hölscher, C., McGlinchey, L., Anwyl, R., & Rowan, M. J. (1997) HFS-induced long-term potentiation and depotentiation in area CA1 of the hippocampus are not good models for learning. Psychopharmacology 130, 174-182.
50. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
51. Hsiao, K. K., Borchelt, D. R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., & Xu, S. (1995) Age related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron 15, 1203-1218.
52. Hu, J., & El-Fakahany, E. E. (1993) β-Amyloid 25-35 activates nitric oxide synthase in a neuronal clone. Neuroreport 4, 760-762.
53. Huang, Z., Huang, P. L., Panahian, N., Dalkara, T., Fishman, M. C., & Moskowitz, M. A. (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265, 1883-1885.
54. Iadecola, C. (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20, 132-138.
55. Ihara, Y., Hayabara, T., Sasaki, K., Fujisawa, Y., Kawada, R., Yamamoto, T., Nakashima, Y., Yoshimune, S., Kawai, M., Kibata, M., & Kuroda, S. (1997) Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia. J. Neurol. Sci. 153, 76-81.
56. Incalzi, R. A., Capparella, O., Gemma, A., Marra, C., & Cargbonin, P. U. (1995) Effects of aging and of Alzheimer's disease on verbal memory. J. Clin. Exp. Neuropsychol. 17, 580-589.
57. Katzman, R. (1976) The prevalence and malignancy of Alzheimer's disease: A major killer. Arch. Neurol. 33, 217-218.
58. Kirazov, L., Löffler, T., Schliebs, R., & Bigl, V. (1997) Glutamate-stimulated secretion of amyloid precursor protein from cortical rat brain slices. Neurochem. Int. 30, 557-563.
59. Kitamura, Y., Shimohama, S., Kamoshima, W., Matsuoka, Y., Nomura, Y., & Taniguchi, T. (1997) Changes of p53 in the brains of patients with Alzheimer's disease. Biochem. Biophys. Res. Commun. 232, 418-421.
60. Klegeris, A., & McGeer, P. L. (1997) Beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J. Neurosci. Res. 49, 229-235.
61. Klein, W., Barlow, A., Chrimy, B., Edwards, C., Freed, R., Lamber, M., Morgan, T., Rozovsky, I., Trommer, B., Viola, K., Wals, P., Zhang, C., Finch, C., & Krafft, G. (1997) "ADDLS" - Soluble Aβ oligomers that cause biphasic loss of hippocampal neuron function and survival. Soc. Neurosci. Meeting New Orleans 23, 648.5.
62. Kordower, J. H., Mufson, E. J., Fox, N., Martel, L., & Emerich, D. F. (1997) Cellular delivery of NGF does not alter the expression of beta-amyloid immunoreactivity in young or aged nonhuman primates. Exp. Neurol. 145, 586-591.
63. Kowall, N., McKee, A., Yankner, B., & Beal, M. (1992) In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment. Neurobiol. Aging 13, 537-542.
64. LaFerla, F. M., Tinkle, B. T., Bieberich, C. J., Haudenschild, C. C., & Jay, G. (1995) The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genet. 9, 21-30.
65. Le, W. D., Colom, L. V., Xie, W., Smith, R. G., Alexianu, M., & Appel, S. H. (1995) Cell death induced by β-amyloid 1-40 in MES 23.5 hybrid clone: The role of nitric oxide and NMDA-gated channel activation leading to apoptosis. Brain Res. 686, 49-60.
66. Lee, R. K. K., Jimenez, J., Cox, A. J., & Wurtman, R. J. (1996) Metabotropic glutamate receptors regulate APP processing in hippocampal neurons and cortical astrocytes derived from fetal rats. Ann. N.Y. Acad. Sci. 777, 338-343.
67. Lee, R., & Wurtman, R. J. (1997) Metabotropic glutamate receptors increase amyloid precursor protein processing in astrocytes: Inhibition by cyclic AMP. J. Neurochem. 68, 1830-1835.
68. Lezoualc'h, F., Sagara, Y., Holsboer, F., & Behl, C. (1998) High constitutive NF-kappaB activity mediates resistance to oxidative stress in neuronal cells. J. Neurosci. 18, 3224-3232.
69. Li, Y. P., Bushnell, A. F., Lee, C. M., Perlmutter, L. S., & Wong, S. (1996) Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res. 738, 196-204.
70. Lockhart, B., Benicourt, C., Junien, J., & Privat, A. (1994) Inhibitors of free radical formation fail to attenuate direct beta-amyloid 25-35 peptide-mediated neurotoxicity in rat hippocampal cultures. J. Neurosci. Res. 39, 494-505.
71. Lorenzo, A., & Yankner, B. A. (1996) Amyloid fibril toxicity in Alzheimer's disease and diabetes. Ann. N.Y. Acad. Sci. 777, 89-95.
72. Lyras, L., Cairns, N. J., Jenner, A., Jenner, P., & Halliwell, B. (1997) An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68, 2061-2069.
73. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372, 92-94.
74. MacGibbon, G. A., Lawlor, P. A., Sirimanne, E. S., Walton, M. R., Connor, B., Young, D., Williams, C., Gluckman, P., Faull, R., Hughes, P., & Dragunow, M. (1997) Bar expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res. 750, 223-234.
75. Maiese, K., Wagner, J., & Boccone, L. (1994) Nitric oxide: A down-stream mediator of calcium toxicity in the ischemic cascade. Neurosci. Lett. 166, 43-47.
76. +-ATPase activity in hippocampal neurons. Brain Res. 756, 205-214.
77. Markesbery, W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biol. Med. 23, 134-147.
78. Masliah, E., Alford, M., DeTeresa, R., Mallory, M., & Hansen, L. (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann. Neurol. 40, 759-766.
79. Masliah, E., Westland, C. E., Rockenstein, E. M., Abraham, C. R., Mallory, M., Veinberg, I., Sheldon, E., & Mucke, L. (1997) Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo. Neuroscience 78, 135-146.
80. Mattson, M. P., & Rydel, R. E. (1992) β-Amyloid precursor protein and Alzheimer's disease: The peptide plot thickens. Neurobiol. Aging 13, 617-621.
81. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16, 409-414.
82. Mattson, M. P., Tomaselli, K. J., & Rydel, R. E. (1993) Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 621, 35-49.
83. Mattson, M. P. (1994) Calcium and neuronal injury in Alzheimer's disease. In: Calcium Hypothesis of Aging and Dementia, pp. 50-76. Ann. N.Y. Acad. Sci., New York.
84. Mattson, M. P. (1995) Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD. Neurobiol. Aging 16, 447-457.
85. Mattson, M. P. (1997) Mother's legacy: Mitochondrial DNA mutations and Alzheimer's disease. Trends Neurosci. 20, 373-379.
86. Mattson, M. P. (1997) Neuroprotective signal transduction: Relevance to stroke. Neurosci. Biobehav. Rev. 21, 193-206.
87. Maurice, T., Lockhart, B. P., Su, T. P., & Privat, A. (1996) Reversion of beta25-35-amyloid peptide-induced amnesia by NMDA receptor-associated glycine site agonists. Brain Res. 731, 249-253.
88. May, P. C., Gitter, B. D., Waters, D. C., Simmons, L. K., Becker, G. W., Small, J. S., & Robinson, P. M. (1992) ̂-Amyloid peptide in vitro toxicity: Lot-to-lot variability. Neurobiol. Aging 13, 605-607.
89. McGeer, P. L., & McGeer, E. G. (1996) Anti-inflammatory drugs in the fight against Alzheimer's disease. Ann. N.Y. Acad. Sci. 777, 213-220.
90. Molina, J., Jimenez-Jimenez, F., Orti-Pareja, M., & Navarro, J. (1998) The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention. Drugs Aging 12, 251-259.
91. Mountjoy, C. Q., Rossor, M. N., Iversen, L. L., & Roth, M. (1984) Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia. Brain 107, 507-518.
92. Mucke, L., Abraham, C. R., & Masliah, E. (1996) Neurotrophic and neuroprotective effects of hAPP in transgenic mice. Ann. N.Y. Acad. Sci. 777, 82-88.
93. Mullan, M., Tsuji, S., Miki, T., Roques, P., Roberts, G., Lantos, P., Crain, B., & Roses, A. (1993) Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val → Ile mutation in the amyloid precursor protein gene. Neurobiol. Aging 14, 407-419.
94. National Institute on Aging (1995) Progress Report on Alzheimer's Disease (NIH Publication 95-3994). U.S. Government Printing Office, Washington, DC.
95. Nicoll, J. A. R., Roberts, G. W., & Graham, D. I. (1995) Apolipoprotein E 4 allele is associated with deposition of amyloid β-protein following head injury. Nature Med. 1, 135-137.
96. Nitsch, R. M., Slack, B. E., & Wurtman, R. J. (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
97. Nitsch, R. M., & Growdon, J. H. (1994) Role of neurotransmission in the regulation of amyloid β-protein precursor processing. Biochem. Pharmacol. 47, 1275-1284.
98. Nitsch, R. M., Deng, A., Wurtman, R. J., & Growdon, J. H. (1997) Metabotropic glutamate receptor subtype mGluR1alpha stimulates the secretion of the amyloid beta-protein precursor ectodomain. J. Neurochem. 69, 704-712.
99. O'Neill, M., Hicks, C., Ward, M., & Panetta, J. A. (1997) Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia. Brain Res. 760, 170-178.
100. Oka, A., & Takashima, S. (1997) Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: Specific localization in affected neurones and axons. Neuroreport 8, 1161-1164.
101. Ouimet, C. C., Baerwald, K. D., Gandy, S. E., & Greengard, P. (1994) Immunocytochemical localization of amyloid precursor protein in rat brain. J. Comp. Neurol. 348, 244-260.
102. Oyama, Y., Chikahisa, L., Ueha, T., Hatakeyama, Y., & Kokubun, T. (1995) Change in membrane permeability induced by amyloid β-protein fragment 25-35 in brain neurons dissociated from rats. Jpn. J. Pharmacol. 68, 77-83.
103. Pappolla, M. A., Chyan, Y. J., Omar, R. A., Hsiao, K., Perry, G., Smith, M. A., & Bozner, P. (1998) Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: A chronic oxidative paradigm for testing antioxidant therapies in vivo. Am. J. Pathol. 152, 871-877.
104. Perelson, A. S., Essunger, P., Cao, Y., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M., & Ho, D. D. (1997) Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387, 188-191.
105. Pike, C. J., Walencewicz, A. J., Glabe, C. G., & Cotman, C. W. (1991) In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311-314.
106. Pike, C. J., Cummings, B. J., & Cotman, C. W. (1992) Beta-amyloid induces neuritic dystrophy in vitro: Similarities with Alzheimer pathology. Neuroreport 3, 769-772.
107. Pollard, H. B., Arispe, N., & Rojas, E. (1995) Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicity. Cell. Mol. Neurobiol. 15, 513-526.
108. Ren, R. F., & Flanders, K. C. (1996) Transforming growth factors-beta protect primary rat hippocampal neuronal cultures from degeneration induced by beta-amyloid peptide. Brain Res. 732, 16-24.
109. Rush, D. K., Aschmies, S., & Merriman, M. C. (1992) Intracerebral β-amyloid (25-35) produces tissue damage: Is it neurotoxic? Neurobiol. Aging 13, 591-594.
110. Sandbrink, R., Masters, C. L., & Beyreuther, K. (1996) APP gene family. Alternative splicing generates functionally related isoforms. Ann. N.Y. Acad. Sci. 777, 281-287.
111. 2+/calmodulin-regulated nitric oxide synthases. Cell Calcium 13, 427-434.
112. Schnabel, J. (1993) New Alzheimer's therapy suggested. Science 260, 1719-1720.
113. Schulz, J. B., Matthews, R. T., Muqit, M. M. K., Browne, S. E., & Beal, M. F. (1995) Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J. Neurochem. 64,936-939.
114. Shin, R., Ogino, K., Kondo, A., Saido, T., Trojanowski, J., Kitamoto, T., & Tateishi, J. (1997) Amyloid beta-protein (Abeta) 1-40 but not Abeta1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain. J. Neurosci. 17, 8187-8193.
115. Shintani, E., & Uchida, K. (1997) Donepezil: An anticholinesterase inhibitor for Alzheimer's disease. Am. J. Health Syst. Pharm. 54, 2805-2810.
116. Singh, I. N., McCartney, D. G., & Kanfer, J. N. (1995) Amyloid beta protein (25-35) stimulation of phospholipases A, C and D activities of LA-N-2 cells. FEBS Lett. 365, 125-128.
117. Small, D. H., Williamson, T., Reed, G., Clarris, H., Beyreuther, K., Masters, C. L., & Nurcombe, V. (1996) The role of heparan sulfate proteoglycans in the pathogenesis of Alzheimer's disease. Ann. N.Y. Acad. Sci. 777, 316-321.
118. Snyder, S. H., & Bredt, D. S. (1992) Biological roles of nitric oxide. Sci. Am. 251, 28-35.
119. Stein-Behrens, B., Adams, K., Yeh, M., & Sapolsky, R. (1992) Failure of beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat. Neurobiol. Aging 13, 577-579.
120. Stratman, N., Carter, D., & Sethy, V. (1997) Ibuprofen: Effect on inducible nitric oxide synthase. Brain Res. Mol. Brain Res. 50, 107-112.
121. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Slavesen, G. S., & Roses, A. D. (1993) Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981.
122. Suo, Z. M., Fang, C. H., Crawford, F., & Mullan, M. (1997) Superoxide free radical and intracellular calcium mediate Abeta(1-42) induced endothelial toxicity. Brain Res. 762, 144-152.
123. Suzuki, N., Cheung, T., Cai, X., Odaka, A., Ötvös, L. J., Eckman, C., Golde, T., & Younkin, S. (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264, 1336-1340.
124. Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) Beta-amyloid-mediated vasoactivity and vascular endothelial damage [see comments]. Nature 380, 168-171.
125. Thorns, V., Hansen, L., & Masliah, E. (1998) nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease. Exp. Neurol. 150, 14-20.
126. Tocco, G., Freire, M. J., Schreiber, S. S., Sakhi, S. H., Aisen, P. S., & Pasinetti, G. M. (1997) Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: Implications for Alzheimer's disease. Exp. Neurol. 144, 339-349.
127. Tremml, P., Müller, U., Lipp, H., & Wolfer, D. (1997) Neurobehavioral development, adult openfield activity and swimming navigation learning in mice underexpressing beta-APP and in mice lacking APLP1. Soc. Neurosci. Meeting New Orleans 23, 636.9.
128. 2+ channels: A possible involvement of free radicals. J. Neurochem. 68, 265-271.
129. Ulus, I. H., & Wurtman, R. J. (1997) Metabotropic glutamate receptor agonists increase release of soluble amyloid precursor protein derivatives from rat brain cortical and hippocampal slices. J. Pharmacol. Exp. Ther. 281, 149-154.
130. Valerio, A., Alberici, A., Paterlini, M., Grilli, M., Galli, P., Pizzi, M., Memo, M., & Spano, P. (1995) Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. NeuroReport 6, 1317-1321.
131. Vodovotz, Y., Lucia, M. S., Flanders, K. C., Chesler, L., Xie, Q. W., Smith, T. W., Weidner, J., Mumford, R., Webber, R., Nathan, C., Roberts, A. B., Lippa, C. F., & Sporn, M. B. (1996) Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Exp. Med. 184, 1425-1433.
132. von Koch, C., Zheng, H., Chen, H., Trumbauer, M., Thinakaran, G., van der Ploeg, L. H., Price, D. L., & Sisodia, S. S. (1997) Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol. Aging 18, 661-669.
133. Weiner, M. F. (1997) Alzheimer's disease: Diagnosis and treatment. Harv. Rev. Psychiatry 4, 306-316.
134. Wisniewski, T., Castano, E. M., Golabek, A., Vogel, T., & Frangione, B. (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol 145, 1030-1035.
135. Wu, J., Anwyl, R., & Rowan, M. (1995) Beta-amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. Neuroreport 6, 2409-2413.
136. Wujek, J. R., Dority, M. D., Frederickson, R. C. A., & Brunden, K. R. (1996) Depostis of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro. Neurobiol. Aging 17, 107-113.
137. Xia, W M., Zhang, J. M., Perez, R., Koo, E. H., & Selkoe, D. (1997) Interaction between amyloid precursor protein and presenilins in mammalian cells: Implications for the pathogenesis of Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 8208-8213.
138. Zhao, B., Chrest, F. J., Horton, W. J., Sisodia, S. S., & Kusiak, J. W. (1997) Expression of mutant amyloid precursor proteins induces apoptosis in PC12 cells. J. Neurosci. Res. 47, 253-263.
139. Zheng, H., Jiang, M. W., Slunt, H. H., Sisodia, S. S., Chen, H. Y., & van der Ploeg, L. H. T. (1996) Mice deficient for the amyloid precursor protein gene. Ann. N. Y. Acad. Sci. 777, 421-426.
140. Zhou, Y., Gopalakrishnan, V., & Richardson, J. S. (1996) Actions of neurotoxic beta-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists. J. Neurochem. 67, 1419-1425.